Roberts Glore & CO Inc Novartis Ag Transaction History

Roberts Glore & CO Inc

  • $341 Million
  • Q3 2024

A detailed history of Roberts Glore & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Roberts Glore & CO Inc holds 14,334 shares of NVS stock, worth $1.5 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
14,334
Previous 14,691 2.43%
Holding current value
$1.5 Million
Previous $1.56 Million 5.37%
% of portfolio
0.48%
Previous 0.48%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $37,888 - $43,157
-357 Reduced 2.43%
14,334 $1.65 Million
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $23,327 - $27,057
-252 Reduced 1.69%
14,691 $1.56 Million
Q1 2024

May 09, 2024
SELL
$95.27 - $108.47 $56,018 - $63,780
-588 Reduced 3.79%
14,943 $1.45 Million
Q4 2023

Feb 12, 2024
SELL
$92.27 - $101.54 $105,649 - $116,263
-1,145 Reduced 6.87%
15,531 $1.57 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $23,682 - $26,282
-250 Reduced 1.48%
16,676 $1.7 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $3,330 - $3,776
-36 Reduced 0.21%
16,926 $1.71 Million
Q1 2023

May 08, 2023
SELL
$80.03 - $92.81 $8,003 - $9,281
-100 Reduced 0.59%
16,962 $1.56 Million
Q4 2022

Feb 13, 2023
BUY
$75.55 - $92.52 $28,709 - $35,157
380 Added 2.28%
17,062 $1.55 Million
Q2 2022

Aug 11, 2022
BUY
$80.52 - $93.75 $9,018 - $10,500
112 Added 0.68%
16,682 $1.41 Million
Q1 2022

May 02, 2022
BUY
$80.11 - $90.62 $8,011 - $9,062
100 Added 0.61%
16,570 $1.45 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $34,510 - $38,160
-433 Reduced 2.56%
16,470 $1.44 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $4,089 - $4,757
50 Added 0.3%
16,903 $1.38 Million
Q2 2021

Aug 10, 2021
SELL
$85.24 - $94.15 $8,524 - $9,415
-100 Reduced 0.59%
16,853 $1.54 Million
Q1 2021

May 06, 2021
SELL
$83.5 - $98.47 $21,877 - $25,799
-262 Reduced 1.52%
16,953 $1.45 Million
Q4 2020

Feb 09, 2021
SELL
$78.07 - $94.43 $1,717 - $2,077
-22 Reduced 0.13%
17,215 $1.63 Million
Q3 2020

Nov 06, 2020
SELL
$82.14 - $91.0 $1,642 - $1,820
-20 Reduced 0.12%
17,237 $1.5 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $40,465 - $45,550
-500 Reduced 2.82%
17,257 $1.51 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $534,863 - $604,741
6,341 Added 55.54%
17,757 $1.68 Million
Q2 2019

Aug 09, 2019
SELL
$75.4 - $92.8 $5,051 - $6,217
-67 Reduced 0.58%
11,416 $1.04 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $33,894 - $38,767
-450 Reduced 3.77%
11,483 $1.1 Million
Q4 2018

Feb 08, 2019
SELL
$73.66 - $82.02 $38,966 - $43,388
-529 Reduced 4.24%
11,933 $1.02 Million
Q3 2018

Nov 09, 2018
BUY
$66.94 - $77.43 $12,183 - $14,092
182 Added 1.48%
12,462 $1.07 Million
Q2 2018

Aug 10, 2018
SELL
$64.91 - $73.36 $12,982 - $14,672
-200 Reduced 1.6%
12,280 $928,000
Q1 2018

May 08, 2018
SELL
$70.39 - $84.15 $5,279 - $6,311
-75 Reduced 0.6%
12,480 $1.01 Million
Q4 2017

Feb 09, 2018
SELL
$72.33 - $77.64 $28,932 - $31,056
-400 Reduced 3.09%
12,555 $1.05 Million
Q3 2017

Nov 08, 2017
BUY
$74.14 - $77.27 $18,535 - $19,317
250 Added 1.97%
12,955 $1.11 Million
Q2 2017

Aug 15, 2017
BUY
N/A
12,705
12,705 $1.06 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $226B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email